郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.

期刊：Journal of medicinal chemistry发表年份：2012作者：Fazel Shabanpoor; Mohammad Akhter Hossain; Philip J Ryan; Alessia Belgi; Sharon Layfield; Martina Kocan; Suode Zhang; Chrishan S Samuel; Andrew L Gundlach; Ross A D Bathgate; Frances Separovic; John D Wade
阅读更多 →

药效评价Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor.

期刊：Journal of medicinal chemistry发表年份：2012作者：Andrés A Trabanco; Gary Tresadern; Gregor J Macdonald; Juan Antonio Vega; Ana Isabel de Lucas; Encarnación Matesanz; Aránzazu García; María Lourdes Linares; Sergio A Alonso de Diego; José Manuel Alonso; Daniel Oehlrich; Abdelah Ahnaou; Wilhelmus Drin
阅读更多 →

药效评价Characterization of the Drosophila adenosine receptor: the effect of adenosine analogs on cAMP signaling in Drosophila cells and their utility for in vivo experiments.

期刊：Journal of neurochemistry发表年份：2012作者：Lucie Kucerova; Vaclav Broz; Jana Fleischmannova; Eva Santruckova; Roman Sidorov; Vladimir Dolezal; Michal Zurovec
阅读更多 →

药效评价Reassessment of the pharmacology of Sphingosine-1-phosphate S1P3 receptor ligands using the DiscoveRx PathHunter™ and Ca2+ release functional assays.

期刊：British journal of pharmacology发表年份：2012作者：D M Riddy; C Stamp; D A Sykes; S J Charlton; M R Dowling
阅读更多 →